11 results
10-K
2018 FY
GOSS
Gossamer Bio Inc
22 Mar 19
Annual report
4:45pm
innovation to develop, strengthen and maintain our proprietary position. We also plan to rely on data exclusivity, market exclusivity and patent term … Safety and Innovation Act established a category of drugs referred to as “breakthrough therapies” that may be eligible to receive breakthrough therapy
424B4
m4vyx7fi9om na6
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
4ab1lmgvt5 m4e
23 Jan 19
IPO registration (amended)
4:39pm
S-1
oyyksen 8q
21 Dec 18
IPO registration
4:39pm
DRS/A
93z4xo
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
twcw6
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next